Selleck Chemicals - Model A2481 -Nadecnemab (Anti-GFRA3)

Nadecnemab (Anti-GFRA3) is an IgG4κ antibody targeting GFRA3 (glial cell derived neurotrophic factor family receptor alpha 3). Nadecnemab can be used for research of osteoarthritis of the knee/pain. MW: 145.5 KD.